Annual Long Term Debt
$0.00
-$4.00 M-100.00%
31 December 2023
Summary:
Spyre Therapeutics annual long term debt is currently $0.00, with the most recent change of -$4.00 million (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$4.62 million (-100.00%). SYRE annual long term debt is now -100.00% below its all-time high of $5.13 million, reached on 01 December 2020.SYRE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
N/A
30 September 2024
Summary:
Spyre Therapeutics quarterly long term debt is not available.SYRE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -100.0% | - |
| 5 y5 years | -100.0% | - |
SYRE Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | |||
| 5 y | 5 years | -100.0% | |||
| alltime | all time | -100.0% |
Spyre Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $3.82 M(-4.5%) |
| Dec 2022 | $4.00 M(-13.4%) | - |
| Dec 2022 | - | $4.00 M(-3.7%) |
| Sept 2022 | - | $4.16 M(-3.6%) |
| June 2022 | - | $4.32 M(-3.4%) |
| Mar 2022 | - | $4.47 M(-3.4%) |
| Dec 2021 | $4.62 M | $4.62 M(-2.6%) |
| Sept 2021 | - | $4.75 M(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $4.88 M(-2.6%) |
| Mar 2021 | - | $5.01 M(-2.3%) |
| Dec 2020 | $5.13 M(+8.8%) | $5.13 M(+3.7%) |
| Sept 2020 | - | $4.95 M(+5.4%) |
| June 2020 | - | $4.70 M(-2.5%) |
| Mar 2020 | - | $4.82 M(+2.2%) |
| Dec 2019 | $4.71 M(>+9900.0%) | $4.71 M(-3.2%) |
| Sept 2019 | - | $4.87 M(+1.1%) |
| June 2019 | - | $4.82 M(+1194.4%) |
| Mar 2019 | - | $372.00 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Spyre Therapeutics annual long term debt?
- What is the all time high annual long term debt for Spyre Therapeutics?
- What is the all time high quarterly long term debt for Spyre Therapeutics?
What is Spyre Therapeutics annual long term debt?
The current annual long term debt of SYRE is $0.00
What is the all time high annual long term debt for Spyre Therapeutics?
Spyre Therapeutics all-time high annual long term debt is $5.13 M
What is the all time high quarterly long term debt for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly long term debt is $5.13 M